Intrathecal Drug Delivery for Pain and Spasticity - a volume in the new Interventional and Neuromodulatory Techniques for Pain Management series - presents state-of-the-art guidance on the full range of intrathecal drug delivery techniques performed today. Asokumar Buvanendran, MD and Sudhir Diwan, M.D., M.S offer expert advice on a variety of procedures to treat chronic non-malignant pain, cancer pain, and spasticity. Comprehensive, evidence-based coverage on selecting and performing these techniques - as well as weighing relative risks and complications - helps you ensure optimum outcomes. With access to the fully searchable text at www.expertconsult.com, you'll have the detailed visual assistance you need right at your fingertips.
- Understand the rationale and scientific evidence behind intrathecal drug delivery techniques and master their execution.
- Optimize outcomes, reduce complications, and minimize risks by adhering to current, evidence-based practice guidelines.
- Apply the newest techniques in intrathecal pump placement, cancer pain management, use of baclofen pumps, and compounding drugs.
- Quickly find the information you need in a user-friendly format with strictly templated chapters supplemented with illustrative line drawings, images, and treatment algorithms.
- Access the fully searchable contents online at expertconsult.com.
TABLE OF CONTENTS
- SECTION I: General Considerations
- Chapter 1: Basic Science of Spinal Receptors
- Chapter 2: Pharmacologic Agents and Compounding of Intrathecal Drugs
- Chapter 3: Polyanalgesia for Implantable Drug Delivery Systems
- Chapter 4: Principles of Patient Management for Intrathecal Analgesia
- Chapter 5: Patient Selection for Intrathecal Infusion to Treat Chronic Pain
- Chapter 6: Patient Preparation
- Chapter 7: Psychological Considerations in IDD
- Chapter 8: Intrathecal Drug Delivery: Medical Necessity, Documentation, Coding and Billing
- SECTION II: Implant Devices
- Chapter 9: Methods of Trials for Consideration of ITDDS
- Chapter 10: Techniques of Implant Placement for Intrathecal Pumps
- Chapter 11: Programmable versus Fixed-Rate Pumps for Intrathecal Drug Delivery
- Chapter 12: SynchroMed EL vs SynchroMed II
- Chapter 13: Minimizing the Risks of Intrathecal Therapy
- Chapter 14: Complications Associated with Intrathecal Drug Delivery Systems
- SECTION III: Evidence-based practice
- Chapter 15: Management of ITDDS in Patients with Co-Morbidities
- Chapter 16: Cost-Effectiveness of Implanted Drug Delivery Systems
- Chapter 17: Neuroaugmentation by Stimulation vs. Intrathecal Drug Delivery Systems
- Chapter 18: Anticoagulation guidelines and Intrathecal Drug Delivery Systems
- Chapter 19: Intrathecal Therapy for Malignant Pain
- SECTION IV: ITDDs for spasticity
- Chapter 20: Intrathecal Baclofen Trialing
- Chapter 21: Baclofen Pump Management
- SECTION V: Future of ITDDs
- Chapter 22: Future of Intrathecal Drug Delivery Systems (including new devices)
- Chapter 23: Trialing for Ziconotide Intrathecal Analgesic Therapy
- Chapter 24: Perioperative Management of Patients with ITDDS
By Asokumar Buvanendran, Associate Professor, Department of Anesthesiology Rush University Medical Center Chicago, IL; Sudhir Diwan, Director of Pain Medicine,Department of Anesthesiology,Director of Quad-Institutional Pain Medicine Fellowship Program,Weill Cornell Medical College and Timothy Deer, MD, President and CEO, The Center for Pain ReliefClinical Professor of Anesthesiology,West Virginia University School of MedicineCharleston, West Virginia